All Stories

  1. Cost-effectiveness of triple therapy with budesonide/glycopyrronium/formoterol fumarate dihydrate compared with dual therapy for the treatment of chronic obstructive pulmonary disease (COPD) in Canada
  2. Canadian Thoracic Society Position Statement on Climate Change and Choice of Inhalers for Patients with Respiratory Disease
  3. Disease burden in individuals with symptomatic undiagnosed asthma or COPD
  4. SABA use as an indicator for asthma exacerbation risk: an observational cohort study (SABINA Canada)
  5. Economic Burden of Chronic Obstructive Pulmonary Disease and Lung Cancer Between 2000 and 2015 in Saskatchewan: Study Protocol
  6. Economic Burden of Chronic Obstructive Pulmonary Disease and Lung Cancer Between 2000 and 2015 in Saskatchewan: Study Protocol (Preprint)
  7. Development and Cost Analysis of a Lung Nodule Management Strategy Combining Artificial Intelligence and Lung-RADS for Baseline Lung Cancer Screening
  8. A randomized controlled trial investigating effects of an individualized pedometer driven walking program on chronic low back pain
  9. Delivering pulmonary rehabilitation during the COVID-19 pandemic: A Canadian Thoracic Society position statement
  10. Over use of short acting beta agonists and impact on physician visits
  11. Key Highlights of the Canadian Thoracic Society’s Position Statement on the Optimization of COPD Management During the Coronavirus Disease 2019 Pandemic
  12. Urban-rural differences in health care utilization and prescription filling for childhood asthma
  13. Economic analysis of new workplace technology including productivity and injury: The case of needle-less injection in swine
  14. The course of asthma: A population‐based 10‐year study examining asthma remission in children diagnosed with asthma in preschool
  15. Effects of Wait Times on Treatment Adherence and Clinical Outcomes in Patients With Severe Sleep-Disordered Breathing
  16. Population-based case-finding to identify subjects with undiagnosed asthma or COPD
  17. Addressing therapeutic questions to help Canadian health care professionals optimize COPD management for their patients during the COVID-19 pandemic
  18. Examination of COPD management in patients hospitalized with an acute exacerbation of COPD
  19. Status of Severe Asthma Management in Canada
  20. An evaluation of management of severe sleep-disordered breathing by non-physician providers
  21. Effects of Clinical Pathways for COPD on Patient, Professional, and Systems Outcomes
  23. Building patient capacity to participate in care during hospitalisation: a scoping review
  24. Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: evidence from the MIST2 randomised controlled trial
  25. Cost-effectiveness of universally funding smoking cessation pharmacotherapy
  26. The educational impact of web-based and face-to-face patient deterioration simulation programs: An interventional trial
  27. An unusual case of scleroderma lung disease
  28. Structured approaches to promote patient and family engagement in treatment in acute care hospital settings: protocol for a systematic scoping review
  29. Evaluating quality of life and cost implications of prophylactic radiotherapy in mesothelioma: Health economic analysis of the SMART trial
  30. The development, implementation and evaluation of clinical pathways for chronic obstructive pulmonary disease (COPD) in Saskatchewan: protocol for an interrupted times series evaluation
  31. Addressing rural and remote access disparities for patients with inflammatory arthritis through video-conferencing and innovative inter-professional care models
  32. Tobacco use and motivation to stop smoking among long-term smokers who are ineligible for lung cancer screening
  33. Management of malignant pleural effusion: challenges and solutions
  34. Evaluation of an alternative care provider clinic for severe sleep-disordered breathing: a study protocol for a randomised controlled trial
  35. Investigating Cost Implications of Incorporating Level III At-Home Testing into a Polysomnography Based Sleep Medicine Program Using Administrative Data
  36. Evaluating Swine Injection Technologies as a Workplace Musculoskeletal Injury Intervention: A Study Protocol
  37. Cost‐effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion
  38. The impact of web-based and face-to-face simulation on patient deterioration and patient safety: protocol for a multi-site multi-method design
  39. Effects of clinical pathways for chronic obstructive pulmonary disease (COPD) on patient, professional and systems outcomes: protocol for a systematic review
  40. Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial
  41. A 58-year-old woman with hypoxia, hypoxaemia, a hole in the heart and a … herring! Intracardiac or extracardiac shunt? That is the question!
  42. Diagnostic accuracy of the Xpert® MTB/RIF assay for extra-pulmonary tuberculosis: a meta-analysis
  43. Walking away from back pain: one step at a time – a community-based randomised controlled trial
  44. Improvement in Obstructive Sleep Apnea Diagnosis and Management Wait Times: A Retrospective Analysis of a Home Management Pathway for Obstructive Sleep Apnea
  45. Comparing Cost of Indwelling Pleural Catheter vs Talc Pleurodesis for Malignant Pleural Effusion
  46. Governments, pay for smoking cessation
  47. Reducing dietary sodium and decreases in cardiovascular disease in Canada